This is a new position for Foresite Capital Management IV, LLC, representing 13.8% of reportable assets under management as of the Sept. 30, 2025, filing. As of Nov. 14, 2025, shares of Cytokinetics …
Foresite Capital Goes Bullish on Cytokinetics (CYTK), Snapping Up 458K Shares
view original post